Dynavax Technologies Corp (DVAX)
12.90
+0.88
(+7.32%)
USD |
NASDAQ |
Nov 08, 15:49
Dynavax Technologies Revenue (Annual): 232.28M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 232.28M |
| December 31, 2022 | 722.68M |
| December 31, 2021 | 439.44M |
| December 31, 2020 | 46.55M |
| December 31, 2019 | 35.22M |
| December 31, 2018 | 8.198M |
| December 31, 2017 | 0.327M |
| December 31, 2016 | 11.04M |
| December 31, 2015 | 4.05M |
| December 31, 2014 | 11.03M |
| December 31, 2013 | 6.113M |
| December 31, 2012 | 5.775M |
| Date | Value |
|---|---|
| December 31, 2011 | 21.61M |
| December 31, 2010 | 23.95M |
| December 31, 2009 | 40.32M |
| December 31, 2008 | 37.09M |
| December 31, 2007 | 14.09M |
| December 31, 2006 | 4.847M |
| December 31, 2005 | 14.66M |
| December 31, 2004 | 14.81M |
| December 31, 2003 | 0.826M |
| December 31, 2002 | 1.427M |
| December 31, 2001 | 2.359M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
35.22M
Minimum
2019
722.68M
Maximum
2022
295.24M
Average
232.28M
Median
2023
Revenue (Annual) Benchmarks
| Biogen Inc | 9.836B |
| Repligen Corp | 638.76M |
| West Pharmaceutical Services Inc | 2.950B |
| XOMA Royalty Corp | 4.758M |
| Xencor Inc | 168.34M |